AZD 4407
Alternative Names: ZD 4407Latest Information Update: 10 Mar 2003
At a glance
- Originator AstraZeneca
- Class Antiasthmatics
- Mechanism of Action 5-lipoxygenase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Chronic obstructive pulmonary disease
Most Recent Events
- 10 Mar 2003 Discontinued - Phase-I for Chronic obstructive pulmonary disease in United Kingdom (unspecified route)
- 26 Jun 2002 Phase-I clinical trials in Chronic obstructive pulmonary disease in United Kingdom (unspecified route)
- 07 Apr 1999 Merger of Astra and Zeneca to form AstraZeneca completed